Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

10
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
10
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

348
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
348
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

18
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
18
Renal Corpuscle01:20

Renal Corpuscle

2.4K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
2.4K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial Dysfunction as a Driver of Neurodegeneration in Parkinson's and Huntington's Disease: Molecular Insights and Emerging Interventions.

Molecular neurobiology·2026
Same author

Nonprecious Core-Shell Catalysts for Durable High-Performance Water Electrolysis.

Journal of the American Chemical Society·2026
Same author

Controlling thermoreversibility and hole conductivity in thermoresponsive ionic biogels using phase morphology for neurohaptics.

Science advances·2026
Same author

Light-induced giant random telegraph noise in CuScP<sub>2</sub>S<sub>6</sub>/MoS<sub>2</sub> heterostructures and their use in noise resilience image inference.

Nature communications·2026
Same author

StaLAENet: A stacked LSTM-nested deep-autoencoder network for identification of antimicrobial resistance of nosocomial pathogens.

Journal of biosciences·2026
Same author

Exploiting the Photoresponse in LiInP<sub>2</sub>Se<sub>6</sub> for Image Processing.

Nano letters·2026
Same journal

Effects of Vitamin D Supplementation on Serum Levels and Gene Expression of IL-10 and IL-35 Among Women with Unexplained Recurrent Spontaneous Abortion.

Recent advances in inflammation & allergy drug discovery·2026
Same journal

Effect of Helicobacter pylori Eradication on Disease Symptoms, Inflammation, and Quality of Life in Patients with Rheumatoid Arthritis: A Non-blinded Prospective Quasi-experimental Study.

Recent advances in inflammation & allergy drug discovery·2026
Same journal

Linarin Inhibits Mast Cell Degranulation and Ameliorates Allergic Rhinitis in Rats by Suppressing ERK/p38 MAPK Signaling Pathway.

Recent advances in inflammation & allergy drug discovery·2026
Same journal

A Review on Anti-inflammatory Agents in Promoting Osteogenesis.

Recent advances in inflammation & allergy drug discovery·2026
Same journal

Rosiglitazone-induced Macrophage Polarization in Systemic Lupus Erythematosus: A Shift Toward Anti-inflammation.

Recent advances in inflammation & allergy drug discovery·2026
Same journal

From Bench to Bowel: A Review of Nanocarrier-based Drug Delivery Strategies in Inflammatory Bowel Disease.

Recent advances in inflammation & allergy drug discovery·2026
See all related articles

Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.8K

Decrypting the Pathological Pathways in IgA Nephropathy.

Rajiv Jash1,2, Kousik Maparu1, Sanket Seksaria1

  • 1Department of Pharmacology, Sanaka Educational Trust's Group Of Institutions, Malandighi, Durgapur, 713212, West Bengal, India.

Recent Advances in Inflammation & Allergy Drug Discovery
|October 23, 2023
PubMed
Summary
This summary is machine-generated.

IgA nephropathy (IgAN) involves aberrant IgA1 triggering immune complexes that damage kidneys. Understanding these pathways reveals potential therapeutic targets for chronic kidney disease.

Keywords:
ESRDIgANTBRI.TGFβfibrosisinflammation

More Related Videos

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

1.9K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

449

Related Experiment Videos

Last Updated: Jul 12, 2025

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.8K
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

1.9K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

449

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • IgA nephropathy (IgAN) is the most common glomerulonephritis, affecting 2 million people annually and often progressing to end-stage renal disease (ESRD).
  • Current understanding of IgAN pathogenesis is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To comprehensively understand the pathogenesis of IgA nephropathy.
  • To identify potential protein targets for therapeutic intervention in IgAN management.

Main Methods:

  • The study reviews the molecular mechanisms underlying IgAN pathogenesis.
  • Focuses on the role of aberrant glycosylation of IgA1 and subsequent immune complex formation.
  • Examines the inflammatory cascade involving complement system, T cells, and cytokines.

Main Results:

  • Aberrantly glycosylated IgA1, due to suppressed β-1, 3 galactosyltransferase, triggers IgG autoantibody formation.
  • Immune complexes (Gd-IgA1) deposit in glomerular mesangial cells via CD71, activating inflammatory pathways.
  • Inflammatory mediators cause mesangial and podocyte damage, initiating a repair process mediated by TGF-β1, leading to fibrosis.

Conclusions:

  • The pathogenesis of IgAN involves a complex interplay of aberrant glycosylation, immune complex deposition, and inflammatory responses.
  • TGF-β1 plays a dual role in inflammation-induced repair and subsequent glomerular fibrosis.
  • Identifying key proteins in this cascade offers potential therapeutic targets for IgAN and chronic kidney disease.